首页 > 最新文献

Journal of Intellectual Disability Research最新文献

英文 中文
Real-Life Functioning in 22q11.2 Deletion Syndrome in Relation to Neurocognitive Abilities and Psychotic Symptoms: A Comparison With Idiopathic Schizophrenia 22q11.2缺失综合征的现实功能与神经认知能力和精神病症状的关系:与特发性精神分裂症的比较
IF 2.1 2区 医学 Q1 EDUCATION, SPECIAL Pub Date : 2024-11-29 DOI: 10.1111/jir.13200
Tommaso Accinni, Marianna Frascarelli, Pierluigi Cordellieri, Georgios D. Kotzalidis, Martina Fanella, Carlo Di Bonaventura, Carolina Putotto, Bruno Marino, Paola Bucci, Luigi Giuliani, Annalisa Maraone, Massimo Pasquini, Fabio Di Fabio, Antonino Buzzanca, the Italian Network for Research on Psychoses

Background

The 22q11.2 deletion syndrome (22q11.2DS) entails intellectual disabilities and higher risk of psychotic disorders. Neurocognitive deficits predict real-life functioning of schizophrenic patients. We investigated real-life functioning in 22q11.2DS, aiming at defining how neurocognitive profile and psychopathological variables impact on psychotic patients' social functioning.

Methods

We recruited 63 patients with schizophrenia (SCZ, N = 63), 44 with 22q11.2DS (DEL, N = 44) and 19 with 22q11.2DS and psychosis (DEL–SCZ, N = 19), all matched for age, sex and neurocognitive profile; we administered the Positive and Negative Syndrome Scale (PANSS), the Brief Negative Symptom Scale (BNSS), the Specific Levels of Functioning (SLoF) scale and the Measurement and Treatment Research to Improve Cognition in Schizophrenia Consensus Cognitive Battery (MCCB). We implemented descriptive analyses, MANCOVA and linear regression statistics.

Results

The DEL–SCZ and the SCZ groups showed similar levels in Interpersonal Relationships (p = 0.093) and Social Acceptability subscales (p = 0.283). The DEL group scored higher on the Interpersonal Relationships subscale compared with the SCZ group (p = 0.001). The groups scored similarly on the other SLoF subscales. Both BNSS total score (beta = −0.343; p = 0.004) and BNSS asociality (beta = −0.487; p = 0.038) significantly predicted the Interpersonal Relationships variable in the groups with psychosis (SCZ and DEL–SCZ).

Discussion and Conclusions

Individuals with 22q11.2DS display a similar real-life functioning to patients with chronic schizophrenia. Social functioning impairments are typical of psychosis regardless of the genetic condition and highly predicted by negative symptoms like asociality. The 22q11.2DS represents a reliable biological model to study vulnerability to psychosis and its consequences on patients' real-life and social functioning.

背景:22q11.2缺失综合征(22q11.2 ds)会导致智力障碍和更高的精神障碍风险。神经认知缺陷预示着精神分裂症患者的现实生活功能。我们调查了22q11.2DS的现实生活功能,旨在确定神经认知特征和精神病理变量如何影响精神病患者的社会功能。方法:我们招募了63例精神分裂症患者(SCZ, N = 63)、44例22q11.2DS患者(DEL, N = 44)和19例22q11.2DS合并精神病患者(DEL-SCZ, N = 19),年龄、性别和神经认知特征均相匹配;采用阳性和阴性症状量表(PANSS)、简短阴性症状量表(BNSS)、特定功能水平量表(SLoF)和改善精神分裂症共识认知电池(MCCB)认知的测量与治疗研究。我们实施了描述性分析、方差分析和线性回归统计。结果:DEL-SCZ组与SCZ组在人际关系量表(p = 0.093)和社会可接受性量表(p = 0.283)上的水平相近。与SCZ组相比,DEL组在人际关系子量表上得分更高(p = 0.001)。两组在其他SLoF量表上的得分相似。两个BNSS总分(beta = -0.343;p = 0.004)和BNSS社会性(β = -0.487;p = 0.038)显著预测精神病组(SCZ和DEL-SCZ)的人际关系变量。讨论与结论:22q11.2DS患者与慢性精神分裂症患者在现实生活中表现出相似的功能。社会功能障碍是精神病的典型特征,与遗传条件无关,并且与社会性等负面症状高度相关。22q11.2DS是研究精神病易感性及其对患者现实生活和社会功能影响的可靠生物学模型。
{"title":"Real-Life Functioning in 22q11.2 Deletion Syndrome in Relation to Neurocognitive Abilities and Psychotic Symptoms: A Comparison With Idiopathic Schizophrenia","authors":"Tommaso Accinni,&nbsp;Marianna Frascarelli,&nbsp;Pierluigi Cordellieri,&nbsp;Georgios D. Kotzalidis,&nbsp;Martina Fanella,&nbsp;Carlo Di Bonaventura,&nbsp;Carolina Putotto,&nbsp;Bruno Marino,&nbsp;Paola Bucci,&nbsp;Luigi Giuliani,&nbsp;Annalisa Maraone,&nbsp;Massimo Pasquini,&nbsp;Fabio Di Fabio,&nbsp;Antonino Buzzanca,&nbsp;the Italian Network for Research on Psychoses","doi":"10.1111/jir.13200","DOIUrl":"10.1111/jir.13200","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>The 22q11.2 deletion syndrome (22q11.2DS) entails intellectual disabilities and higher risk of psychotic disorders. Neurocognitive deficits predict real-life functioning of schizophrenic patients. We investigated real-life functioning in 22q11.2DS, aiming at defining how neurocognitive profile and psychopathological variables impact on psychotic patients' social functioning.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We recruited 63 patients with schizophrenia (SCZ, <i>N</i> = 63), 44 with 22q11.2DS (DEL, <i>N</i> = 44) and 19 with 22q11.2DS and psychosis (DEL–SCZ, <i>N</i> = 19), all matched for age, sex and neurocognitive profile; we administered the Positive and Negative Syndrome Scale (PANSS), the Brief Negative Symptom Scale (BNSS), the Specific Levels of Functioning (SLoF) scale and the Measurement and Treatment Research to Improve Cognition in Schizophrenia Consensus Cognitive Battery (MCCB). We implemented descriptive analyses, MANCOVA and linear regression statistics.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The DEL–SCZ and the SCZ groups showed similar levels in <i>Interpersonal Relationships</i> (<i>p</i> = 0.093) and <i>Social Acceptability</i> subscales (<i>p</i> = 0.283). The DEL group scored higher on the <i>Interpersonal Relationships</i> subscale compared with the SCZ group (<i>p</i> = 0.001). The groups scored similarly on the other SLoF subscales. Both BNSS total score (beta = −0.343; <i>p</i> = 0.004) and BNSS asociality (beta = −0.487; <i>p</i> = 0.038) significantly predicted the <i>Interpersonal Relationships</i> variable in the groups with psychosis (SCZ and DEL–SCZ).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusions</h3>\u0000 \u0000 <p>Individuals with 22q11.2DS display a similar real-life functioning to patients with chronic schizophrenia. <i>Social functioning</i> impairments are typical of psychosis regardless of the genetic condition and highly predicted by negative symptoms like asociality. The 22q11.2DS represents a reliable biological model to study vulnerability to psychosis and its consequences on patients' real-life and social functioning.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16163,"journal":{"name":"Journal of Intellectual Disability Research","volume":"69 3","pages":"177-192"},"PeriodicalIF":2.1,"publicationDate":"2024-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jir.13200","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142755122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association Between Intellectual Disability and Hair Cortisol Concentration in Adolescents in a Brazilian Population-Based Birth Cohort 巴西人口出生队列中青少年智力障碍与毛发皮质醇浓度之间的关系。
IF 2.1 2区 医学 Q1 EDUCATION, SPECIAL Pub Date : 2024-11-27 DOI: 10.1111/jir.13204
Karen Y. Sánchez-Luquez, Simone de Menezes Karam, Aluisio J. D. Barros, Andrea Gonzalez, Joseph Murray, Isabel O. de Oliveira, Alicia Matijasevich, Iná S. Santos, Luciana Tovo-Rodrigues

Objective

Children with intellectual disability (ID) usually exhibit neuroendocrine functioning impairment, such as alterations in the hypothalamic–pituitary–adrenal (HPA) neuroendocrine axis, which can result in glucocorticoid cortisol release alterations. Indeed, many studies showed a positive association between ID and cortisol concentration. However, evidence is lacking on the relationship between child neurodevelopment and cortisol levels during adolescence in population-based studies. We aimed to test the association between ID and hair cortisol concentration (HCC) during adolescence in a prospective population-based cohort.

Methods

Data from 1770 individuals in the 2004 Pelotas Birth Cohort were used. ID was diagnosed at age 6 through clinical examination. Hair cortisol was measured at age 15. Association was assessed using linear regression models adjusted for sex, socio-economic factors, hair-related variables and corticosteroid use.

Results

Higher HCC were observed in individuals with ID (β: 1.120; 95% CI: 1.012, 1.241) in the analysis adjusted for sex, hair-related variables and corticosteroid use. Compared to the other aetiological groups, this was more evident in idiopathic ID. But this did not remain significant when demographics/socio-economic variables were controlled for.

Conclusion

Children with ID, particularly those with idiopathic ID, might exhibit dysfunction in the HPA axis or experience heightened stress levels during adolescence.

目的:智障(ID)儿童通常表现出神经内分泌功能障碍,如下丘脑-垂体-肾上腺(HPA)神经内分泌轴的改变,这会导致糖皮质激素皮质醇释放的改变。事实上,许多研究表明,ID 与皮质醇浓度之间存在正相关。然而,在以人群为基础的研究中,关于儿童神经发育与青春期皮质醇水平之间关系的证据还很缺乏。我们的目的是在一项前瞻性人群队列研究中检验 ID 与青春期毛发皮质醇浓度(HCC)之间的关系:我们使用了 2004 年佩洛塔斯出生队列中 1770 人的数据。6岁时通过临床检查诊断出ID。在 15 岁时测量毛发皮质醇。使用线性回归模型评估了与皮质醇的关系,并对性别、社会经济因素、头发相关变量和皮质类固醇的使用进行了调整:结果:在对性别、头发相关变量和皮质类固醇使用情况进行调整后的分析中发现,ID 患者的 HCC 较高(β:1.120;95% CI:1.012,1.241)。与其他病因组相比,这在特发性 ID 中更为明显。但在对人口统计学/社会经济变量进行控制后,这一结果并不显著:结论:ID患儿,尤其是特发性ID患儿,在青春期可能会出现HPA轴功能障碍或压力水平升高。
{"title":"Association Between Intellectual Disability and Hair Cortisol Concentration in Adolescents in a Brazilian Population-Based Birth Cohort","authors":"Karen Y. Sánchez-Luquez,&nbsp;Simone de Menezes Karam,&nbsp;Aluisio J. D. Barros,&nbsp;Andrea Gonzalez,&nbsp;Joseph Murray,&nbsp;Isabel O. de Oliveira,&nbsp;Alicia Matijasevich,&nbsp;Iná S. Santos,&nbsp;Luciana Tovo-Rodrigues","doi":"10.1111/jir.13204","DOIUrl":"10.1111/jir.13204","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>Children with intellectual disability (ID) usually exhibit neuroendocrine functioning impairment, such as alterations in the hypothalamic–pituitary–adrenal (HPA) neuroendocrine axis, which can result in glucocorticoid cortisol release alterations. Indeed, many studies showed a positive association between ID and cortisol concentration. However, evidence is lacking on the relationship between child neurodevelopment and cortisol levels during adolescence in population-based studies. We aimed to test the association between ID and hair cortisol concentration (HCC) during adolescence in a prospective population-based cohort.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Data from 1770 individuals in the 2004 Pelotas Birth Cohort were used. ID was diagnosed at age 6 through clinical examination. Hair cortisol was measured at age 15. Association was assessed using linear regression models adjusted for sex, socio-economic factors, hair-related variables and corticosteroid use.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Higher HCC were observed in individuals with ID (<i>β</i>: 1.120; 95% CI: 1.012, 1.241) in the analysis adjusted for sex, hair-related variables and corticosteroid use. Compared to the other aetiological groups, this was more evident in idiopathic ID. But this did not remain significant when demographics/socio-economic variables were controlled for.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Children with ID, particularly those with idiopathic ID, might exhibit dysfunction in the HPA axis or experience heightened stress levels during adolescence.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16163,"journal":{"name":"Journal of Intellectual Disability Research","volume":"69 3","pages":"214-223"},"PeriodicalIF":2.1,"publicationDate":"2024-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142729671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adults With Intellectual Disabilities and Incontinence: Assessment and Toileting Issues 智障成人与大小便失禁:评估和如厕问题。
IF 2.1 2区 医学 Q1 EDUCATION, SPECIAL Pub Date : 2024-11-24 DOI: 10.1111/jir.13202
Janet Finlayson, Dawn A. Skelton, Paul Ord, Fiona Roche, Audrey Marshall, John Butcher, Nick Gore

Background

Urinary and bowel incontinence are more common in adults with intellectual disability (ID), compared to the general population. Little is known about their incontinence experiences and toileting issues. The aim was to learn about their experiences and toileting issues.

Method

Incontinence and toileting issues assessment was conducted with a community-based sample of 22 adults with ID and urinary incontinence, with or without bowel incontinence. Assessment included the IPSS, ICIQ-UI, and POTI checklists; bladder scans; and urine sample screening for presence of a urinary tract infection.

Results

The majority (19 adults, 86%) developed urinary incontinence during adulthood. Seven adults (32%) also experienced bowel incontinence, and constipation was the most commonly reported health condition (13 adults, 59%), other than urinary incontinence. Fifty per cent (11 adults) had been treated for a urinary tract infection within the previous 12 months.

Conclusion

There is an urgent need to develop accessible and reliable incontinence assessment materials with and for adults with ID and their supporters. These assessments should pay close attention to health conditions that can cause incontinence in this group and factors associated with incontinence which are more commonly experienced by adults with ID. These factors are potentially modifiable.

背景:与普通人相比,智障成人更容易发生尿失禁和大便失禁。人们对他们的尿失禁经历和如厕问题知之甚少。本研究旨在了解他们的尿失禁经历和如厕问题:对 22 名患有尿失禁(伴有或不伴有大便失禁)的智障成人进行了尿失禁和如厕问题评估。评估内容包括 IPSS、ICIQ-UI 和 POTI 检查表;膀胱扫描;以及尿液样本筛查,以确定是否存在尿路感染:大多数患者(19 名成人,86%)在成年后出现尿失禁。除尿失禁外,7 名成人(32%)还出现了大便失禁,便秘是最常见的健康问题(13 名成人,59%)。50%的成年人(11 人)在过去 12 个月内接受过尿路感染治疗:当务之急是为智障成人及其支持者开发方便可靠的尿失禁评估材料。这些评估应密切关注可导致该群体尿失禁的健康状况,以及与智障成人更常见的尿失禁相关的因素。这些因素可能是可以改变的。
{"title":"Adults With Intellectual Disabilities and Incontinence: Assessment and Toileting Issues","authors":"Janet Finlayson,&nbsp;Dawn A. Skelton,&nbsp;Paul Ord,&nbsp;Fiona Roche,&nbsp;Audrey Marshall,&nbsp;John Butcher,&nbsp;Nick Gore","doi":"10.1111/jir.13202","DOIUrl":"10.1111/jir.13202","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Urinary and bowel incontinence are more common in adults with intellectual disability (ID), compared to the general population. Little is known about their incontinence experiences and toileting issues. The aim was to learn about their experiences and toileting issues.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Method</h3>\u0000 \u0000 <p>Incontinence and toileting issues assessment was conducted with a community-based sample of 22 adults with ID and urinary incontinence, with or without bowel incontinence. Assessment included the <i>IPSS</i>, <i>ICIQ-UI</i>, and <i>POTI</i> checklists; bladder scans; and urine sample screening for presence of a urinary tract infection.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The majority (19 adults, 86%) developed urinary incontinence during adulthood. Seven adults (32%) also experienced bowel incontinence, and constipation was the most commonly reported health condition (13 adults, 59%), other than urinary incontinence. Fifty per cent (11 adults) had been treated for a urinary tract infection within the previous 12 months.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>There is an urgent need to develop accessible and reliable incontinence assessment materials with and for adults with ID and their supporters. These assessments should pay close attention to health conditions that can cause incontinence in this group and factors associated with incontinence which are more commonly experienced by adults with ID. These factors are potentially modifiable.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16163,"journal":{"name":"Journal of Intellectual Disability Research","volume":"69 2","pages":"165-175"},"PeriodicalIF":2.1,"publicationDate":"2024-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11735887/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142709680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The needs of family members of people with severe or profound intellectual disabilities when collaborating with healthcare professionals: a systematic review 重度或极重度智障人士的家庭成员在与医护人员合作时的需求:系统性综述。
IF 2.1 2区 医学 Q1 EDUCATION, SPECIAL Pub Date : 2024-11-21 DOI: 10.1111/jir.13199
K. van Beurden, F. R. Vereijken, N. Frielink, P. J. C. M. Embregts

Background

Collaboration with healthcare professionals is crucial in arranging necessary lifelong support for people with intellectual disabilities. However, family members often face challenges when collaborating with healthcare professionals. Family members of people with severe and profound intellectual disabilities often encounter many professionals due to medical needs and the severity of their disability. Therefore, providing a comprehensive overview of existing literature on the needs and experiences of family members of relatives with severe or profound intellectual disabilities when collaborating with healthcare professionals is needed to provide insight into how to stimulate and support collaboration.

Method

The review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. Seven databases were systematically searched and a thematic analysis was conducted on 23 studies.

Results

Five overarching themes were identified: (1) need for a balanced view of their relative; (2) need for recognition and compassion; (3) healthcare professionals facilitating close and active involvement; (4) desired qualities of healthcare professionals and (5) conditions for successful interaction between family members and healthcare professionals.

Conclusions

The results indicated distinct needs that family members had for themselves and their relatives, as well as desired qualities (e.g. trustworthiness) and supporting factors (e.g. information). Furthermore, the review highlighted persisting needs, such as the need for information and empathy, as well as emerging needs, such as the desire to be recognised as experts and to develop personal bonds with healthcare professionals. These insights can inform future research by identifying areas that require deeper exploration.

背景:在为智障人士安排必要的终身支持时,与医疗保健专业人员的合作至关重要。然而,家庭成员在与医护专业人员合作时往往面临挑战。由于医疗需求和残疾的严重程度,重度和极重度智障人士的家庭成员往往会遇到许多专业人员。因此,有必要对现有文献进行全面概述,了解重度或极重度智障亲属的家庭成员在与医护专业人员合作时的需求和经历,从而为如何促进和支持合作提供深入见解:综述按照系统综述和元分析首选报告项目 (PRISMA) 声明进行。对七个数据库进行了系统检索,并对 23 项研究进行了专题分析:结果:确定了五大主题:(1) 需要对其亲属有一个平衡的看法;(2) 需要认可和同情;(3) 医疗保健专业人员促进密切和积极的参与;(4) 医疗保健专业人员的理想素质;(5) 家庭成员和医疗保健专业人员之间成功互动的条件:研究结果表明了家庭成员对自身及其亲属的独特需求,以及所期望的品质(如值得信赖)和支持因素(如信息)。此外,综述还强调了一些持续存在的需求,如对信息和同理心的需求,以及一些新出现的需求,如被认可为专家的愿望和与医疗保健专业人员建立个人联系的愿望。这些见解可以为今后的研究提供参考,确定需要深入探讨的领域。
{"title":"The needs of family members of people with severe or profound intellectual disabilities when collaborating with healthcare professionals: a systematic review","authors":"K. van Beurden,&nbsp;F. R. Vereijken,&nbsp;N. Frielink,&nbsp;P. J. C. M. Embregts","doi":"10.1111/jir.13199","DOIUrl":"10.1111/jir.13199","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Collaboration with healthcare professionals is crucial in arranging necessary lifelong support for people with intellectual disabilities. However, family members often face challenges when collaborating with healthcare professionals. Family members of people with severe and profound intellectual disabilities often encounter many professionals due to medical needs and the severity of their disability. Therefore, providing a comprehensive overview of existing literature on the needs and experiences of family members of relatives with severe or profound intellectual disabilities when collaborating with healthcare professionals is needed to provide insight into how to stimulate and support collaboration.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Method</h3>\u0000 \u0000 <p>The review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. Seven databases were systematically searched and a thematic analysis was conducted on 23 studies.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Five overarching themes were identified: (1) need for a balanced view of their relative; (2) need for recognition and compassion; (3) healthcare professionals facilitating close and active involvement; (4) desired qualities of healthcare professionals and (5) conditions for successful interaction between family members and healthcare professionals.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>The results indicated distinct needs that family members had for themselves and their relatives, as well as desired qualities (e.g. trustworthiness) and supporting factors (e.g. information). Furthermore, the review highlighted persisting needs, such as the need for information and empathy, as well as emerging needs, such as the desire to be recognised as experts and to develop personal bonds with healthcare professionals. These insights can inform future research by identifying areas that require deeper exploration.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16163,"journal":{"name":"Journal of Intellectual Disability Research","volume":"69 1","pages":"1-29"},"PeriodicalIF":2.1,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11621588/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142681880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Eating and feeding disorders in adults with intellectual developmental disorder with and without autism spectrum disorder 患有或未患有自闭症谱系障碍的智力发育障碍成人的进食和喂养障碍。
IF 2.1 2区 医学 Q1 EDUCATION, SPECIAL Pub Date : 2024-11-07 DOI: 10.1111/jir.13195
M. O. Bertelli, F. Paletti, M. Piva Merli, A. Hassiotis, A. Bianco, S. Lassi

Background

The present observational cross-sectional study aimed at investigating the prevalence of feeding and eating disorders (FEEDs) in adults with intellectual disability (ID)/intellectual developmental disorder (IDD) with or without autism spectrum disorder (ASD) and specific problem behaviours (PBs).

Methods

Two hundred six adults with ID/IDD consecutively attending residential and rehabilitative facilities, 59.2% of which had co-occurring ASD, were assessed for presence of FEEDs by a structured interview specifically developed for the study and Diagnostic Manual – Intellectual Disability criteria.

Results

The 4.3% of the sample fully met the diagnostic criteria for anorexia nervosa, 6.7% for bulimia nervosa (BN) and 22.8% for binge eating disorder (BED). Furthermore, at least one observable symptom of these disorders was found in higher percentages of the sample. A higher prevalence of FEEDs was found in ID/IDD plus ASD than in ID/IDD alone. PBs were also significantly higher in participants with co-occurring ASD and had a positive correlation with the number of FEED symptoms, especially for BN and BED.

Conclusions

The study enriches previous literature and considers novel aspects such as the behavioural/observable presentation of symptoms as well as the association with ASD and PBs. These issues deserve a specific consideration within standard psychiatric assessment and future research, especially in persons with major communication and/or cognitive difficulties.

研究背景本观察性横断面研究旨在调查伴有或不伴有自闭症谱系障碍(ASD)和特定问题行为(PBs)的智障/智力发育障碍(IDD)成人中进食和饮食紊乱(FEEDs)的患病率:通过专门为本研究制定的结构化访谈和《诊断手册--智力残疾》标准,对连续入住寄宿和康复机构的 26 名智障/智力发育障碍成人(其中 59.2% 的人同时伴有自闭症谱系障碍)是否存在 FEEDs 进行了评估:4.3%的样本完全符合神经性厌食症的诊断标准,6.7%符合神经性贪食症(BN)的诊断标准,22.8%符合暴饮暴食症(BED)的诊断标准。此外,样本中至少有一种可观察到的这些疾病症状的比例也较高。与单纯的 ID/IDD 相比,ID/IDD 加 ASD 的 FEED 患病率更高。同时患有 ASD 的参与者的 PBs 也明显较高,并且与 FEED 症状的数量呈正相关,尤其是 BN 和 BED:该研究丰富了以往的文献,并考虑了一些新的方面,如症状的行为/可观察表现以及与 ASD 和 PBs 的关联。这些问题值得在标准精神评估和未来研究中予以特别考虑,尤其是对有严重沟通和/或认知障碍的人。
{"title":"Eating and feeding disorders in adults with intellectual developmental disorder with and without autism spectrum disorder","authors":"M. O. Bertelli,&nbsp;F. Paletti,&nbsp;M. Piva Merli,&nbsp;A. Hassiotis,&nbsp;A. Bianco,&nbsp;S. Lassi","doi":"10.1111/jir.13195","DOIUrl":"10.1111/jir.13195","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>The present observational cross-sectional study aimed at investigating the prevalence of feeding and eating disorders (FEEDs) in adults with intellectual disability (ID)/intellectual developmental disorder (IDD) with or without autism spectrum disorder (ASD) and specific problem behaviours (PBs).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Two hundred six adults with ID/IDD consecutively attending residential and rehabilitative facilities, 59.2% of which had co-occurring ASD, were assessed for presence of FEEDs by a structured interview specifically developed for the study and Diagnostic Manual – Intellectual Disability criteria.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The 4.3% of the sample fully met the diagnostic criteria for anorexia nervosa, 6.7% for bulimia nervosa (BN) and 22.8% for binge eating disorder (BED). Furthermore, at least one observable symptom of these disorders was found in higher percentages of the sample. A higher prevalence of FEEDs was found in ID/IDD plus ASD than in ID/IDD alone. PBs were also significantly higher in participants with co-occurring ASD and had a positive correlation with the number of FEED symptoms, especially for BN and BED.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>The study enriches previous literature and considers novel aspects such as the behavioural/observable presentation of symptoms as well as the association with ASD and PBs. These issues deserve a specific consideration within standard psychiatric assessment and future research, especially in persons with major communication and/or cognitive difficulties.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16163,"journal":{"name":"Journal of Intellectual Disability Research","volume":"69 2","pages":"153-164"},"PeriodicalIF":2.1,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142590858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High frequency of mitochondrial DNA rearrangements in the peripheral blood of adults with intellectual disability 智障成人外周血中线粒体 DNA 重排的频率很高。
IF 2.1 2区 医学 Q1 EDUCATION, SPECIAL Pub Date : 2024-11-06 DOI: 10.1111/jir.13197
B. K. Bulduk, J. Tortajada, L. Torres-Egurrola, A. Valiente-Pallejà, R. Martínez-Leal, E. Vilella, H. Torrell, G. Muntané, L. Martorell

Background

Mitochondrial DNA (mtDNA) rearrangements are recognised factors in mitochondrial disorders and ageing, but their involvement in neurodevelopmental disorders, particularly intellectual disability (ID) and autism spectrum disorder (ASD), remains poorly understood. Previous studies have reported mitochondrial dysfunction in individuals with both ID and ASD. The aim of this study was to investigate the prevalence of large-scale mtDNA rearrangements in ID and ID with comorbid ASD (ID-ASD).

Method

We used mtDNA-targeted next-generation sequencing and the MitoSAlt high-throughput computational pipeline in peripheral blood samples from 76 patients with ID (mean age 52.5 years, 37% female), 59 patients with ID-ASD (mean age 41.3 years, 46% female) and 32 healthy controls (mean age 42.4 years, 47% female) from Catalonia.

Results

The study revealed a high frequency of mtDNA rearrangements in patients with ID, with 10/76 (13.2%) affected individuals. However, the prevalence was significantly lower in patients with ID-ASD 1/59 (1.7%) and in HC 1/32 (3.1%). Among the mtDNA rearrangements, six were identified as deletions (median size 6937 bp and median heteroplasmy level 2.3%) and six as duplications (median size 10 455 bp and median heteroplasmy level 1.9%). One of the duplications, MT-ATP6 m.8765-8793dup (29 bp), was present in four individuals with ID with a median heteroplasmy level of 3.9%.

Conclusions

Our results show that mtDNA rearrangements are frequent in patients with ID, but not in those with ID-ASD, when compared to HC. Additionally, MitoSAlt has demonstrated high sensitivity and accuracy in detecting mtDNA rearrangements, even at very low heteroplasmy levels in blood samples. While the high frequency of mtDNA rearrangements in ID is noteworthy, the role of these rearrangements is currently unclear and needs to be confirmed with further data, particularly in post-mitotic tissues and through age-matched control studies.

背景:线粒体 DNA(mtDNA)重排是线粒体疾病和老龄化的公认因素,但人们对线粒体 DNA 重排参与神经发育疾病,尤其是智障(ID)和自闭症谱系障碍(ASD)的情况仍知之甚少。以前的研究曾报道过智力障碍和自闭症谱系障碍患者的线粒体功能障碍。本研究旨在调查线粒体DNA大规模重排在ID和ID合并自闭症谱系障碍(ID-ASD)患者中的发生率:我们使用mtDNA靶向新一代测序技术和MitoSAlt高通量计算管道,对来自加泰罗尼亚的76名ID患者(平均年龄52.5岁,37%为女性)、59名ID-ASD患者(平均年龄41.3岁,46%为女性)和32名健康对照者(平均年龄42.4岁,47%为女性)的外周血样本进行了检测:研究发现,ID 患者中 mtDNA 重排的频率很高,10/76(13.2%)人受到影响。然而,在ID-ASD患者和HC患者中,这一比例分别为1/59(1.7%)和1/32(3.1%),明显较低。在mtDNA重排中,有6个被鉴定为缺失(中位数大小为6937 bp,中位数异质性水平为2.3%),6个被鉴定为重复(中位数大小为10 455 bp,中位数异质性水平为1.9%)。其中一个重复序列,即 MT-ATP6 m.8765-8793dup (29 bp),出现在 4 个 ID 患者中,中位异源性水平为 3.9%:我们的研究结果表明,与 HC 相比,mtDNA 重排在 ID 患者中很常见,但在 ID-ASD 患者中并不常见。此外,MitoSAlt 在检测 mtDNA 重排方面表现出极高的灵敏度和准确性,即使血液样本中的异质性水平很低。虽然ID中mtDNA重排的高频率值得注意,但这些重排的作用目前尚不清楚,需要进一步的数据来证实,特别是在有丝分裂后组织中和通过年龄匹配的对照研究。
{"title":"High frequency of mitochondrial DNA rearrangements in the peripheral blood of adults with intellectual disability","authors":"B. K. Bulduk,&nbsp;J. Tortajada,&nbsp;L. Torres-Egurrola,&nbsp;A. Valiente-Pallejà,&nbsp;R. Martínez-Leal,&nbsp;E. Vilella,&nbsp;H. Torrell,&nbsp;G. Muntané,&nbsp;L. Martorell","doi":"10.1111/jir.13197","DOIUrl":"10.1111/jir.13197","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Mitochondrial DNA (mtDNA) rearrangements are recognised factors in mitochondrial disorders and ageing, but their involvement in neurodevelopmental disorders, particularly intellectual disability (ID) and autism spectrum disorder (ASD), remains poorly understood. Previous studies have reported mitochondrial dysfunction in individuals with both ID and ASD. The aim of this study was to investigate the prevalence of large-scale mtDNA rearrangements in ID and ID with comorbid ASD (ID-ASD).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Method</h3>\u0000 \u0000 <p>We used mtDNA-targeted next-generation sequencing and the MitoSAlt high-throughput computational pipeline in peripheral blood samples from 76 patients with ID (mean age 52.5 years, 37% female), 59 patients with ID-ASD (mean age 41.3 years, 46% female) and 32 healthy controls (mean age 42.4 years, 47% female) from Catalonia.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The study revealed a high frequency of mtDNA rearrangements in patients with ID, with 10/76 (13.2%) affected individuals. However, the prevalence was significantly lower in patients with ID-ASD 1/59 (1.7%) and in HC 1/32 (3.1%). Among the mtDNA rearrangements, six were identified as deletions (median size 6937 bp and median heteroplasmy level 2.3%) and six as duplications (median size 10 455 bp and median heteroplasmy level 1.9%). One of the duplications, <i>MT-ATP6</i> m.8765-8793dup (29 bp), was present in four individuals with ID with a median heteroplasmy level of 3.9%.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Our results show that mtDNA rearrangements are frequent in patients with ID, but not in those with ID-ASD, when compared to HC. Additionally, MitoSAlt has demonstrated high sensitivity and accuracy in detecting mtDNA rearrangements, even at very low heteroplasmy levels in blood samples. While the high frequency of mtDNA rearrangements in ID is noteworthy, the role of these rearrangements is currently unclear and needs to be confirmed with further data, particularly in post-mitotic tissues and through age-matched control studies.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16163,"journal":{"name":"Journal of Intellectual Disability Research","volume":"69 2","pages":"137-152"},"PeriodicalIF":2.1,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11735882/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142590864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and evaluation of the Trauma Screener-Intellectual Disability: a post-traumatic stress disorder screening tool for adults with mild intellectual disability or borderline intellectual functioning 创伤筛查器--智力障碍的开发与评估:针对轻度智力障碍或边缘智力功能的成年人的创伤后应激障碍筛查工具。
IF 2.1 2区 医学 Q1 EDUCATION, SPECIAL Pub Date : 2024-11-04 DOI: 10.1111/jir.13198
A. Versluis, C. Schuengel, L. Mevissen, A. de Jongh, R. Didden

Background

This study aimed to evaluate the validity and reliability of the adult self-report and proxy version of the Trauma Screener-Intellectual Disability (TS-ID) in adults with mild intellectual disability or borderline intellectual functioning (MID-BIF). An optimal cut-off value was determined for the ratio of specificity to sensitivity for predicting the diagnosis of post-traumatic stress disorder (PTSD).

Methods

The TS-ID was adapted from a Dutch Child and Adolescent Trauma Screener, for use with adults with MID-BIF. Outcomes based on the TS-ID were compared with the presence of PTSD, as classified using the Diagnostic Interview Trauma and Stressors–Intellectual Disability (Mevissen et al. 2018). The TS-ID adult version was administered to 97 participants with MID-BIF who lived in supported housing, whereas the TS-ID proxy version was administered to 92 family members or professional caregivers.

Results

The TS-ID adult version showed high internal consistency (Cronbach's α = .94) and excellent validity (AUC = .94) for distinguishing PTSD in adults with MID-BIF. Optimal specificity and sensitivity was found at a cut-off score of 18. Although the TS-ID proxy version demonstrated excellent internal consistency (Cronbach's α = .93), it showed no validity in statistically distinguishing PTSD in adults with MID-BIF.

Conclusions

The TS-ID showed favourable psychometric qualities as a screening instrument of PTSD in the case for people with MID-BIF.

背景:本研究旨在评估轻度智力障碍或边缘智力功能(MID-BIF)成人自我报告和代理版创伤筛查智力障碍(TS-ID)的有效性和可靠性。确定了预测创伤后应激障碍(PTSD)诊断的特异性与敏感性比率的最佳临界值:方法:TS-ID 是根据荷兰儿童和青少年创伤筛查工具改编的,适用于患有 MID-BIF 的成年人。根据TS-ID得出的结果与创伤后应激障碍的存在进行了比较,创伤后应激障碍是通过创伤和压力-智力障碍诊断访谈进行分类的(Mevissen等人,2018年)。TS-ID成人版对97名居住在辅助住房的MID-BIF参与者进行了测试,而TS-ID代理版则对92名家庭成员或专业护理人员进行了测试:TS-ID成人版在区分MID-BIF成人创伤后应激障碍方面显示出较高的内部一致性(Cronbach's α = .94)和出色的有效性(AUC = .94)。最佳特异性和灵敏度的临界值为 18 分。尽管TS-ID代理版本显示出极好的内部一致性(Cronbach's α = .93),但它在统计区分MID-BIF成人创伤后应激障碍方面没有显示出有效性:结论:TS-ID作为创伤后应激障碍的筛查工具,在MID-BIF患者中显示出良好的心理测量质量。
{"title":"Development and evaluation of the Trauma Screener-Intellectual Disability: a post-traumatic stress disorder screening tool for adults with mild intellectual disability or borderline intellectual functioning","authors":"A. Versluis,&nbsp;C. Schuengel,&nbsp;L. Mevissen,&nbsp;A. de Jongh,&nbsp;R. Didden","doi":"10.1111/jir.13198","DOIUrl":"10.1111/jir.13198","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>This study aimed to evaluate the validity and reliability of the adult self-report and proxy version of the Trauma Screener-Intellectual Disability (TS-ID) in adults with mild intellectual disability or borderline intellectual functioning (MID-BIF). An optimal cut-off value was determined for the ratio of specificity to sensitivity for predicting the diagnosis of post-traumatic stress disorder (PTSD).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>The TS-ID was adapted from a Dutch Child and Adolescent Trauma Screener, for use with adults with MID-BIF. Outcomes based on the TS-ID were compared with the presence of PTSD, as classified using the Diagnostic Interview Trauma and Stressors–Intellectual Disability (Mevissen <i>et al</i>. 2018). The TS-ID adult version was administered to 97 participants with MID-BIF who lived in supported housing, whereas the TS-ID proxy version was administered to 92 family members or professional caregivers.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The TS-ID adult version showed high internal consistency (Cronbach's α = .94) and excellent validity (AUC = .94) for distinguishing PTSD in adults with MID-BIF. Optimal specificity and sensitivity was found at a cut-off score of 18. Although the TS-ID proxy version demonstrated excellent internal consistency (Cronbach's <i>α =</i> .93), it showed no validity in statistically distinguishing PTSD in adults with MID-BIF.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>The TS-ID showed favourable psychometric qualities as a screening instrument of PTSD in the case for people with MID-BIF.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16163,"journal":{"name":"Journal of Intellectual Disability Research","volume":"69 2","pages":"127-136"},"PeriodicalIF":2.1,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11735870/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142576406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A comprehensive overview of neuropsychiatric symptoms in adolescents with 22q11.2 deletion syndrome 全面概述 22q11.2 缺失综合征青少年的神经精神症状。
IF 2.1 2区 医学 Q1 EDUCATION, SPECIAL Pub Date : 2024-10-22 DOI: 10.1111/jir.13196
I. Selten, J. Blok, T. Boerma, A. A. A. M. J. Djelantik, M. Houben, F. Wijnen, J. Zinkstok, J. A. S. Vorstman, A. M. Fiksinski

Background

The 22q11.2 deletion syndrome (22q11DS) is associated with a variety of neuropsychiatric outcomes that vary across deletion carriers. We adopted a dimensional approach to provide a comprehensive overview of neuropsychiatric symptom expression in adolescents with 22q11DS and further our understanding of the observed phenotypical heterogeneity.

Methods

Participants were 208 adolescents with 22q11DS between 10 and 19 years old. Semi-structured clinical interviews and IQ tests were used to quantify symptom expression on multiple symptom dimensions, some reflecting DSM-IV diagnostic domains. We investigated symptom expression in those with and without a formal DSM-IV classification and examined between and within symptom dimensions. We used correlation analyses to explore associations between different symptom dimensions.

Results

We demonstrated inter-individual differences in symptom expression, both between and within neuropsychiatric symptom dimensions. On most symptom dimensions, more than 50% of adolescents expressed at least one clinically relevant symptom. In addition, a significant proportion of youth without a formal DSM-IV diagnosis reported clinically relevant symptoms (e.g. >85% of those without an ADHD diagnosis reported ADHD symptoms). The exploratory correlation analysis indicated mostly positive correlations between symptom dimensions.

Conclusions

The finding that most adolescents with 22q11DS express neuropsychiatric symptoms, even in the absence of a DSM-IV classification, has substantial ramifications for guiding adequate support. Findings may spur further research into the dimensional structure of neuropsychiatric symptoms in 22q11DS and aid in uncovering mechanisms that contribute to symptom expression. Ultimately, this provides leads to improve clinical care for 22q11DS and to understand phenotypical variation in other high-risk genetic variants.

背景:22q11.2 缺失综合征(22q11DS22q11.2缺失综合征(22q11DS)与多种神经精神症状有关,不同缺失携带者的神经精神症状各不相同。我们采用了一种维度方法来全面概述 22q11DS 青少年的神经精神症状表现,并进一步了解所观察到的表型异质性:参与者为208名10至19岁患有22q11DS的青少年。采用半结构化临床访谈和智商测试来量化多个症状维度的症状表现,其中一些症状反映了 DSM-IV 诊断领域。我们调查了有DSM-IV正式分类和没有DSM-IV正式分类的患者的症状表现,并检查了症状维度之间和内部的情况。我们使用相关性分析来探讨不同症状维度之间的关联:结果:我们发现了神经精神症状维度之间和内部的个体间症状表现差异。在大多数症状维度上,50%以上的青少年至少表现出一种临床相关症状。此外,相当一部分未被DSM-IV正式诊断的青少年也报告了临床相关症状(例如,在未被诊断为多动症的青少年中,超过85%的人报告了多动症症状)。探索性相关分析表明,症状各维度之间大多呈正相关:即使在没有 DSM-IV 分类的情况下,大多数患有 22q11DS 的青少年也会表现出神经精神症状,这一发现对指导提供适当的支持具有重要意义。研究结果可能会促进对 22q11DS 神经精神症状维度结构的进一步研究,并有助于发现导致症状表现的机制。最终,这将为改善 22q11DS 的临床治疗和了解其他高风险基因变异的表型变异提供线索。
{"title":"A comprehensive overview of neuropsychiatric symptoms in adolescents with 22q11.2 deletion syndrome","authors":"I. Selten,&nbsp;J. Blok,&nbsp;T. Boerma,&nbsp;A. A. A. M. J. Djelantik,&nbsp;M. Houben,&nbsp;F. Wijnen,&nbsp;J. Zinkstok,&nbsp;J. A. S. Vorstman,&nbsp;A. M. Fiksinski","doi":"10.1111/jir.13196","DOIUrl":"10.1111/jir.13196","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>The 22q11.2 deletion syndrome (22q11DS) is associated with a variety of neuropsychiatric outcomes that vary across deletion carriers. We adopted a dimensional approach to provide a comprehensive overview of neuropsychiatric symptom expression in adolescents with 22q11DS and further our understanding of the observed phenotypical heterogeneity.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Participants were 208 adolescents with 22q11DS between 10 and 19 years old. Semi-structured clinical interviews and IQ tests were used to quantify symptom expression on multiple symptom dimensions, some reflecting DSM-IV diagnostic domains. We investigated symptom expression in those with and without a formal DSM-IV classification and examined between and within symptom dimensions. We used correlation analyses to explore associations between different symptom dimensions.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>We demonstrated inter-individual differences in symptom expression, both between and within neuropsychiatric symptom dimensions. On most symptom dimensions, more than 50% of adolescents expressed at least one clinically relevant symptom. In addition, a significant proportion of youth without a formal DSM-IV diagnosis reported clinically relevant symptoms (e.g. &gt;85% of those without an ADHD diagnosis reported ADHD symptoms). The exploratory correlation analysis indicated mostly positive correlations between symptom dimensions.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>The finding that most adolescents with 22q11DS express neuropsychiatric symptoms, even in the absence of a DSM-IV classification, has substantial ramifications for guiding adequate support. Findings may spur further research into the dimensional structure of neuropsychiatric symptoms in 22q11DS and aid in uncovering mechanisms that contribute to symptom expression. Ultimately, this provides leads to improve clinical care for 22q11DS and to understand phenotypical variation in other high-risk genetic variants.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16163,"journal":{"name":"Journal of Intellectual Disability Research","volume":"69 2","pages":"113-126"},"PeriodicalIF":2.1,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11735868/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142502156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inpatient hospitalisations for patients with Prader–Willi syndrome: a 2019–2021 National Inpatient Sample analysis 普拉德-威利综合征患者的住院情况:2019-2021年全国住院病人抽样分析。
IF 2.1 2区 医学 Q1 EDUCATION, SPECIAL Pub Date : 2024-10-22 DOI: 10.1111/jir.13194
J. Luccarelli, T. V. Strong, T. H. McCoy Jr

Background

Prader–Willi syndrome (PWS) is a genetic disorder characterised by hyperphagia, intellectual disability and increased propensity to a range of medical disorders. To better characterise the clinical presentation of PWS across the lifespan, this study reports on the demographics and clinical diagnosis of individuals with PWS hospitalised in the United States.

Methods

The National Inpatient Sample, an all-payor administrative claims database of hospitalisations in the United States, was queried for patients with a coded diagnosis of PWS from October 2019 through December 2021. Hospitalisations for patients with PWS were matched to five non-PWS hospitalisations based on age, sex, year and hospital characteristics.

Results

There were 4400 (95% CI: 3,885 to 4,915) PWS hospitalisations, with a median age of 24. Compared to controls, PWS hospitalisations had longer hospital stays (median 5 vs. 3 days) and higher in-hospital mortality (2.2% vs. 1.3%). Infectious (19.0%) and respiratory (16.2%) diagnoses were most common for PWS patients. Codes for overweight or obesity were present in 38.1% of PWS hospitalisations, with Hispanic ethnicity was associated with a higher odds of overweight/obesity in PWS patients (aOR 1.73; 95% CI: 1.11–2.71).

Conclusions

PWS hospitalisations are characterised by higher healthcare utilisation and complexity compared to matched controls. The high prevalence of obesity and significant rates of infectious and respiratory conditions highlight specific health challenges for PWS patients. Validation of the Q87.11 administrative claims code is an essential step for ongoing health services research in this condition.

背景:普拉德-威利综合征(PWS)是一种遗传性疾病,其特点是吞咽功能亢进、智力障碍以及易患一系列内科疾病。为了更好地描述 PWS 在整个生命周期中的临床表现,本研究报告了在美国住院的 PWS 患者的人口统计学和临床诊断情况:方法:从2019年10月到2021年12月,我们查询了美国全国住院病人抽样调查(National Inpatient Sample),这是一个关于美国住院病人的全付费行政索赔数据库。根据年龄、性别、年份和医院特征,将PWS患者的住院病例与5例非PWS住院病例进行匹配:共有4400例(95% CI:3885至4915例)PWS住院病例,中位年龄为24岁。与对照组相比,PWS住院患者的住院时间更长(中位数为5天对3天),院内死亡率更高(2.2%对1.3%)。PWS患者最常见的诊断是感染(19.0%)和呼吸系统(16.2%)。38.1%的PWS住院患者存在超重或肥胖的代码,西班牙裔与PWS患者超重/肥胖的几率较高有关(aOR 1.73;95% CI:1.11-2.71):结论:与匹配的对照组相比,PWS 患者的住院治疗具有更高的医疗利用率和复杂性。肥胖症的高发率以及感染性疾病和呼吸系统疾病的高发率凸显了PWS患者所面临的特殊健康挑战。对Q87.11行政索赔代码进行验证是对该病症进行持续医疗服务研究的必要步骤。
{"title":"Inpatient hospitalisations for patients with Prader–Willi syndrome: a 2019–2021 National Inpatient Sample analysis","authors":"J. Luccarelli,&nbsp;T. V. Strong,&nbsp;T. H. McCoy Jr","doi":"10.1111/jir.13194","DOIUrl":"10.1111/jir.13194","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Prader–Willi syndrome (PWS) is a genetic disorder characterised by hyperphagia, intellectual disability and increased propensity to a range of medical disorders. To better characterise the clinical presentation of PWS across the lifespan, this study reports on the demographics and clinical diagnosis of individuals with PWS hospitalised in the United States.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>The National Inpatient Sample, an all-payor administrative claims database of hospitalisations in the United States, was queried for patients with a coded diagnosis of PWS from October 2019 through December 2021. Hospitalisations for patients with PWS were matched to five non-PWS hospitalisations based on age, sex, year and hospital characteristics.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>There were 4400 (95% CI: 3,885 to 4,915) PWS hospitalisations, with a median age of 24. Compared to controls, PWS hospitalisations had longer hospital stays (median 5 vs. 3 days) and higher in-hospital mortality (2.2% vs. 1.3%). Infectious (19.0%) and respiratory (16.2%) diagnoses were most common for PWS patients. Codes for overweight or obesity were present in 38.1% of PWS hospitalisations, with Hispanic ethnicity was associated with a higher odds of overweight/obesity in PWS patients (aOR 1.73; 95% CI: 1.11–2.71).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>PWS hospitalisations are characterised by higher healthcare utilisation and complexity compared to matched controls. The high prevalence of obesity and significant rates of infectious and respiratory conditions highlight specific health challenges for PWS patients. Validation of the Q87.11 administrative claims code is an essential step for ongoing health services research in this condition.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16163,"journal":{"name":"Journal of Intellectual Disability Research","volume":"69 1","pages":"79-89"},"PeriodicalIF":2.1,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142467581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of orthopaedic conditions in Rett syndrome: a systematic review and meta-analysis 雷特综合征骨科疾病的患病率:系统回顾和荟萃分析。
IF 2.1 2区 医学 Q1 EDUCATION, SPECIAL Pub Date : 2024-10-21 DOI: 10.1111/jir.13193
M. Galán-Olleros, E. González-Alguacil, V. Soto-Insuga, M. T. Vara-Arias, N. V. Ortiz-Cabrera, R. M. Egea-Gámez, J. J. García-Peñas, I. Martínez-Caballero, RTT-HNJ, Rett Syndrome Multidisciplinary Group of Hospital Infantil Universitario Niño Jesús

Background

Rett syndrome (RTT), a developmental disorder primarily affecting girls and linked to methyl-CpG binding protein-2 (MECP2) gene mutations, presents musculoskeletal abnormalities with varying prevalence across studies and age groups. Our aim was to delineate the prevalence of orthopaedic conditions in individuals with RTT.

Method

Three databases were searched and independently screened by two reviewers to retrieve observational studies published after 2000 that recruited 10 or more patients diagnosed with RTT and reported the prevalence of any orthopaedic conditions (scoliosis, hip displacement, knee problems or foot deformities). A random-effects meta-analysis was performed to determine the pooled prevalence based on study weight.

Results

Of 867 screened studies, 21 studies involving 9997 girls with RTT (mean age 14.1 years; range, 3–38.5) met the inclusion criteria. The pooled prevalence of scoliosis was 64.5% [95% confidence interval (CI) 55.4–73.6%; I2 = 99%; P < 0.01], of hip displacement was 29.6% (95% CI 8.9–50.2%; I2 = 97%; P < 0.01) and of foot deformities was 53% (95% CI 17.5–89.2%; I2 = 98%; P < 0.01). Knee problems were reported in only one study. Scoliosis prevalence increased in studies with a high percentage of genetic testing and MECP2 positivity [69.1% (95% CI 58.9–79.2%; I2 = 99%; P < 0.01)], those with a mean age over 13 years [73% (95% CI 59.1–87%; I2 = 100%; P < 0.01)], and studies combining both variables [80.13% (95% CI 70.8–89.4%; I2 = 81%; P < 0.01)].

Conclusions

This meta-analysis found that approximately two in three girls with RTT develop scoliosis, one in two exhibit foot deformities and one in three experience hip displacement. These findings enhance our understanding of the prevalence of orthopaedic conditions in RTT, which can guide the establishment of surveillance protocols, clinical guidelines and management strategies tailored to the needs of RTT patients.

背景:雷特综合征(RTT)是一种主要影响女孩的发育障碍,与甲基-CpG结合蛋白-2(MECP2)基因突变有关。我们的目的是界定 RTT 患者骨科疾病的发病率:我们检索了三个数据库,并由两名审稿人进行独立筛选,以检索 2000 年后发表的观察性研究,这些研究招募了 10 名或以上被诊断为 RTT 的患者,并报告了任何骨科疾病(脊柱侧弯、髋关节移位、膝关节问题或足部畸形)的患病率。我们进行了随机效应荟萃分析,以确定基于研究权重的汇总患病率:在筛选出的 867 项研究中,有 21 项研究符合纳入标准,这些研究涉及 9997 名患有 RTT 的女孩(平均年龄为 14.1 岁;年龄范围为 3-38.5 岁)。脊柱侧弯的合计患病率为 64.5% [95% 置信区间 (CI) 55.4-73.6%;I2 = 99%;P 2 = 97%;P 2 = 98%;P 2 = 99%;P 2 = 100%;P 2 = 81%;P 结论:这项荟萃分析发现,大约每三个 RTT 女孩中就有两个会出现脊柱侧弯,每两个女孩中就有一个会出现足部畸形,每三个女孩中就有一个会出现髋关节移位。这些发现加深了我们对RTT骨科疾病患病率的了解,可指导制定适合RTT患者需求的监测方案、临床指南和管理策略。
{"title":"Prevalence of orthopaedic conditions in Rett syndrome: a systematic review and meta-analysis","authors":"M. Galán-Olleros,&nbsp;E. González-Alguacil,&nbsp;V. Soto-Insuga,&nbsp;M. T. Vara-Arias,&nbsp;N. V. Ortiz-Cabrera,&nbsp;R. M. Egea-Gámez,&nbsp;J. J. García-Peñas,&nbsp;I. Martínez-Caballero,&nbsp;RTT-HNJ, Rett Syndrome Multidisciplinary Group of Hospital Infantil Universitario Niño Jesús","doi":"10.1111/jir.13193","DOIUrl":"10.1111/jir.13193","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Rett syndrome (RTT), a developmental disorder primarily affecting girls and linked to methyl-CpG binding protein-2 (MECP2) gene mutations, presents musculoskeletal abnormalities with varying prevalence across studies and age groups. Our aim was to delineate the prevalence of orthopaedic conditions in individuals with RTT.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Method</h3>\u0000 \u0000 <p>Three databases were searched and independently screened by two reviewers to retrieve observational studies published after 2000 that recruited 10 or more patients diagnosed with RTT and reported the prevalence of any orthopaedic conditions (scoliosis, hip displacement, knee problems or foot deformities). A random-effects meta-analysis was performed to determine the pooled prevalence based on study weight.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Of 867 screened studies, 21 studies involving 9997 girls with RTT (mean age 14.1 years; range, 3–38.5) met the inclusion criteria. The pooled prevalence of scoliosis was 64.5% [95% confidence interval (CI) 55.4–73.6%; <i>I</i><sup>2</sup> = 99%; <i>P</i> &lt; 0.01], of hip displacement was 29.6% (95% CI 8.9–50.2%; <i>I</i><sup>2</sup> = 97%; <i>P</i> &lt; 0.01) and of foot deformities was 53% (95% CI 17.5–89.2%; <i>I</i><sup>2</sup> = 98%; <i>P</i> &lt; 0.01). Knee problems were reported in only one study. Scoliosis prevalence increased in studies with a high percentage of genetic testing and MECP2 positivity [69.1% (95% CI 58.9–79.2%; <i>I</i><sup>2</sup> = 99%; <i>P</i> &lt; 0.01)], those with a mean age over 13 years [73% (95% CI 59.1–87%; <i>I</i><sup>2</sup> = 100%; <i>P</i> &lt; 0.01)], and studies combining both variables [80.13% (95% CI 70.8–89.4%; <i>I</i><sup>2</sup> = 81%; <i>P</i> &lt; 0.01)].</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>This meta-analysis found that approximately two in three girls with RTT develop scoliosis, one in two exhibit foot deformities and one in three experience hip displacement. These findings enhance our understanding of the prevalence of orthopaedic conditions in RTT, which can guide the establishment of surveillance protocols, clinical guidelines and management strategies tailored to the needs of RTT patients.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16163,"journal":{"name":"Journal of Intellectual Disability Research","volume":"68 12","pages":"1331-1343"},"PeriodicalIF":2.1,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jir.13193","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142467616","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Intellectual Disability Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1